AG
Artal Group Portfolio holdings
AUM
$930M
This Quarter Return
+38.55%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$2.94B
AUM Growth
+$2.94B
(+40%)
Cap. Flow
-$16M
Cap. Flow
% of AUM
-0.55%
Top 10 Holdings %
Top 10 Hldgs %
47.94%
Holding
134
New
28
Increased
21
Reduced
57
Closed
5
Top Buys
| 1 |
GDS Holdings
GDS
|
$87.6M |
| 2 |
Generation Bio
GBIO
|
$59.1M |
| 3 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$37.7M |
| 4 |
Royalty Pharma
RPRX
|
$36.4M |
| 5 |
NovaGold Resources
NG
|
$23.9M |
Top Sells
| 1 |
Moderna
MRNA
|
$161M |
| 2 |
Avantor
AVTR
|
$42.5M |
| 3 |
PayPal
PYPL
|
$41.8M |
| 4 |
Alnylam Pharmaceuticals
ALNY
|
$29.6M |
| 5 |
Zillow
Z
|
$24M |
Sector Composition
| 1 | Healthcare | 75.63% |
| 2 | Consumer Discretionary | 16.28% |
| 3 | Technology | 3.84% |
| 4 | Financials | 1.19% |
| 5 | Communication Services | 0.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
WW
1
DELISTED
WW International
WW
| $376M | 10.52% | 14,818,300 | – | – |
|
|
ONC
2
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $160M | 4.48% | 850,000 +200,000 | +31% | +$37.7M |
|
3
BioNTech
BNTX
$24B
| $133M | 3.73% | 2,000,000 -228,130 | -10% | -$15.2M |
|
|
XLRN
4
DELISTED
Acceleron Pharma Inc.
XLRN
| $133M | 3.73% | 1,400,000 -100,000 | -7% | -$9.53M |
|
|
5
Alnylam Pharmaceuticals
ALNY
$58.5B
| $133M | 3.73% | 900,000 -200,000 | -18% | -$29.6M |
|
6
Lexicon Pharmaceuticals
LXRX
$400M
| $120M | 3.36% | 60,240,864 | – | – |
|
7
argenx
ARGX
$43.6B
| $101M | 2.84% | 450,000 -25,000 | -5% | -$5.63M |
|
|
8
GDS Holdings
GDS
$6.62B
| $87.6M | 2.45% | +1,100,000 | New | +$87.6M |
|
9
Schrodinger
SDGR
$1.44B
| $82.2M | 2.3% | 897,445 | – | – |
|
10
Alibaba
BABA
$322B
| $80.3M | 2.25% | 372,500 -27,500 | -7% | -$5.93M |
|
11
Black Diamond Therapeutics
BDTX
$157M
| $65.2M | 1.82% | 1,546,517 -150,000 | -9% | -$6.32M |
|
12
Fate Therapeutics
FATE
$120M
| $61.8M | 1.73% | 1,800,000 -300,000 | -14% | -$10.3M |
|
|
13
Generation Bio
GBIO
$40.4M
| $59.1M | 1.65% | +2,814,191 | New | +$59.1M |
|
14
Amicus Therapeutics
FOLD
$2.34B
| $52.8M | 1.48% | 3,500,000 -1,500,000 | -30% | -$22.6M |
|
15
Scholar Rock
SRRK
$3.14B
| $46M | 1.29% | 2,524,040 -22,000 | -0.9% | -$401K |
|
|
MORF
16
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $45.2M | 1.26% | 1,669,186 -150,000 | -8% | -$4.06M |
|
17
uniQure
QURE
$896M
| $45.1M | 1.26% | 1,000,000 -150,000 | -13% | -$6.76M |
|
|
BPMC
18
DELISTED
Blueprint Medicines
BPMC
| $42.9M | 1.2% | 550,000 +150,000 | +38% | +$11.7M |
|
|
DCPH
19
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $38.8M | 1.09% | 650,000 -150,000 | -19% | -$8.96M |
|
20
Atara Biotherapeutics
ATRA
$84.6M
| $36.4M | 1.02% | 2,500,000 | – | – |
|
|
21
Royalty Pharma
RPRX
$15.6B
| $36.4M | 1.02% | +750,000 | New | +$36.4M |
|
|
22
PayPal
PYPL
$67.1B
| $34.8M | 0.98% | 200,000 -240,000 | -55% | -$41.8M |
|
23
Gossamer Bio
GOSS
$562M
| $34.6M | 0.97% | 2,658,968 +850,000 | +47% | +$11.1M |
|
24
TG Therapeutics
TGTX
$4.65B
| $34.1M | 0.95% | 1,750,000 +750,000 | +75% | +$14.6M |
|
|
25
Avantor
AVTR
$9.18B
| $34M | 0.95% | 2,000,000 -2,500,000 | -56% | -$42.5M |
|